FOXP3 and neoplasm: The abundance of CD8+ T cells and FoxP3+ T regulatory cells (Tregs), as well as PD-L1 expression by tumor and stromal cells in the tumor microenvironment (TME), are predictors of prognosis and response to immunotherapy in human NSCLC and melanoma (22).